StreetInsider.com News Articles

Bristol Myers buys Nvidia's latest AI computing system for drug research

Mon, 20 Jul 2026 07:01:16 -0400

By Michael Erman

NEW YORK, July ‌20 (Reuters) - Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence across its ‌drug discovery and development operations.

The drugmaker said it will be the ⁠first life sciences company to buy an Nvidia DGX SuperPOD based on its

Bristol Myers buys Nvidia's latest AI computing system for drug research

Mon, 20 Jul 2026 07:01:16 -0400

By Michael Erman

The drugmaker said it will be the ⁠first life sciences company to buy an Nvidia DGX SuperPOD based on its

Bristol Myers buys Nvidia's latest AI computing system for drug research

Mon, 20 Jul 2026 07:01:16 -0400

By Michael Erman

The drugmaker said it will be the ⁠first life sciences company to buy an Nvidia DGX SuperPOD based on its

Bristol Myers buys Nvidia's latest AI computing system for drug research

Mon, 20 Jul 2026 07:01:16 -0400

By Michael Erman

The drugmaker said it will be the ⁠first life sciences company to buy an Nvidia DGX SuperPOD based on its

Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery

Mon, 20 Jul 2026 06:59:38 -0400

Bristol Myers Squibb (NYSE: BMY) announced it will deploy an Nvidia DGX SuperPOD with DGX Vera Rubin NVL72 systems, expanding its existing compute infrastructure as part of a collaboration with Nvidia that began nearly three years ago.

According to the company, the Vera Rubin architecture delivers up to ten times greater performance per megawatt compared to its predecessor, which BMS said will allow it to run larger AI workloads without a proportional increase in energy consumption.

The infrastructure is intended to support AI-driven research across oncology, hematology, cardiovascular, immunology, and neuroscience. BMS said it will use the cluster to develop foundation models

Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery

Mon, 20 Jul 2026 06:59:38 -0400

The infrastructure is intended to support AI-driven research across oncology, hematology, cardiovascular, immunology, and neuroscience. BMS said it will use the cluster to develop foundation models

Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery

Mon, 20 Jul 2026 06:59:38 -0400

The infrastructure is intended to support AI-driven research across oncology, hematology, cardiovascular, immunology, and neuroscience. BMS said it will use the cluster to develop foundation models

Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery

Mon, 20 Jul 2026 06:59:38 -0400

The infrastructure is intended to support AI-driven research across oncology, hematology, cardiovascular, immunology, and neuroscience. BMS said it will use the cluster to develop foundation models

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Mon, 20 Jul 2026 06:59:00 -0400

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences

BMS will deploy NVIDIA DGX Vera Rubin NVL72 systems to scale proprietary AI models, compress discovery timelines, and advance its vision of collaborative hybrid intelligence, where AI scientists work alongside researchers to pursue first- and best-in-class medicines

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY, “BMS”), a global biopharmaceutical leader, today announced it will expand its compute infrastructure to deploy an NVIDIA DGX SuperPOD with DGX Vera Rubin NVL72 systems, giving BMS the most powerful and energy-efficient single-owned

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Mon, 20 Jul 2026 06:59:00 -0400

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Mon, 20 Jul 2026 06:59:00 -0400

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Mon, 20 Jul 2026 06:59:00 -0400

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Mon, 20 Jul 2026 06:59:00 -0400

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Mon, 20 Jul 2026 06:59:00 -0400

Expanded collaboration gives BMS the most advanced and most energy-efficient NVIDIA infrastructure in life sciences

FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma